Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medico Remedies has informed that it enclosed Investor Presentation for Q2 FY 2023-24 of the Company.
The above information is a part of company’s filings submitted to BSE.